Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish.
about
Automated high-content live animal drug screening using C. elegans expressing the aggregation prone serpin α1-antitrypsin ZZebrafish as an Emerging Model Organism to Study Angiogenesis in Development and RegenerationIndirubin and Indirubin Derivatives for Counteracting Proliferative DiseasesHooking the big one: the potential of zebrafish xenotransplantation to reform cancer drug screening in the genomic eraDevelopment and validation of an automated high-throughput system for zebrafish in vivo screeningsHigh-content screening in zebrafish embryos identifies butafenacil as a potent inducer of anemiaOptimisation of embryonic and larval ECG measurement in zebrafish for quantifying the effect of QT prolonging drugsZebrafish small molecule screens: Taking the phenotypic plungeZebrafish as a disease model for studying human hepatocellular carcinomaAutomated phenotype recognition for zebrafish embryo based in vivo high throughput toxicity screening of engineered nano-materialsZebrafish: an in vivo model for nano EHS studiesChemical screening for hair cell loss and protection in the zebrafish lateral lineZebrafish bioassay-guided natural product discovery: isolation of angiogenesis inhibitors from East African medicinal plantsAutomated reporter quantification in vivo: high-throughput screening method for reporter-based assays in zebrafishThe anti-cancer agent SU4312 unexpectedly protects against MPP(+) -induced neurotoxicity via selective and direct inhibition of neuronal NOSCurrent approaches for the discovery of drugs that deter substance and drug abuse.Advancements in zebrafish applications for 21st century toxicology.Small molecule screen for compounds that affect vascular development in the zebrafish retinaAn in vivo chemical library screen in Xenopus tadpoles reveals novel pathways involved in angiogenesis and lymphangiogenesisCancer and virus leads by HTS, chemical design and SEA data miningA high-throughput biophotonics instrument to screen for novel ocular photosensitizing therapeutic agentsHigh-throughput screening and small animal models, where are we?Automated image-based phenotypic analysis in zebrafish embryos.Analysis of the retina in the zebrafish model.YLT192, a novel, orally active bioavailable inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy in preclinical modelsIdentification of phosphorylase kinase as a novel therapeutic target through high-throughput screening for anti-angiogenesis compounds in zebrafish.Functional inhibition of UQCRB suppresses angiogenesis in zebrafish.Phenotype-based high-content chemical library screening identifies statins as inhibitors of in vivo lymphangiogenesis15 years of zebrafish chemical screeningIn vitro and in vivo structure and activity relationship analysis of polymethoxylated flavonoids: identifying sinensetin as a novel antiangiogenesis agent.A zebrafish in vivo phenotypic assay to identify 3-aminothiophene-2-carboxylic acid-based angiogenesis inhibitors.Small molecule screening in zebrafish: swimming in potential drug therapies.Evaluating human cancer cell metastasis in zebrafish.A manual small molecule screen approaching high-throughput using zebrafish embryos.Anti-cancer drug discovery: update and comparisons in yeast, Drosophila, and zebrafish.Identification of compounds that modulate retinol signaling using a cell-based qHTS assay.Kaempferol Identified by Zebrafish Assay and Fine Fractionations Strategy from Dysosma versipellis Inhibits Angiogenesis through VEGF and FGF Pathways.Alkaloids with Cardiovascular Effects from the Marine-Derived Fungus Penicillium expansum Y32.Chemical screening in zebrafish for novel biological and therapeutic discovery.A novel microtubule-modulating agent EM011 inhibits angiogenesis by repressing the HIF-1α axis and disrupting cell polarity and migration
P2860
Q21562132-45A7DB99-8680-4214-9D47-6A438FA63E4EQ26751145-23D262D9-B160-4DA2-B2C8-36DA37A83C7FQ26784341-583BC78A-575C-458F-9447-1E5B501BDFD3Q27024966-69451536-6610-479F-8A30-E288B641ADAAQ27303272-7B446C50-4A94-49FD-ACC2-5831033F6B9FQ27316428-6F04CC50-5CB9-4A7C-B5B2-5093EA078494Q27330065-3D5F080A-0092-4F9A-8FE0-E605D5DB7F53Q28073655-3A0318C4-E02A-4F45-AE9A-09A36F55D8F9Q28081542-C3956B34-F59F-406D-B786-8C5AD6BC1CA0Q28383295-A8C8FDB5-028F-4910-8437-77DF4EF92A2BQ28388653-A614F210-D90C-48F5-9766-11582A1863C4Q28468560-5344FE27-BC09-4BB9-8D18-0D4EBF3AED36Q28477190-18E7A9D2-6E55-4078-A4DF-6A92F0CAA1EBQ28478706-911D877C-0B21-4BC9-A958-44A44B957A94Q28583196-96AFCB94-06EF-4CE0-8BED-9B90857CAE9AQ28973615-3357D740-0E45-4453-9A9A-168217EE677AQ30386096-FF5C19D9-8B58-4FE2-ADC0-5250472332CCQ30491582-730FE5A6-897A-4B7D-861F-661A31852E94Q33455334-0447F524-6C89-41CC-96B9-DEC55503B180Q33508912-36D90DC8-C4B5-4199-812C-C07FB5C105A0Q33510871-D42E07A0-6C90-465E-8FDE-9DD941D2CEB5Q33566144-A2DAA53D-1D7A-4229-84A3-FE5A32A30287Q33818305-49F75B22-A016-4BD8-A46C-46FE923CDA3DQ33997893-7E9ED032-1492-4EA0-9579-65E0337E6C35Q34030791-F51E33FA-095D-4953-AC8C-57298D6E9D7EQ34104818-13B2B024-7D71-4CA0-8AAE-C30272FBC132Q34330614-28114C08-995F-47ED-ABB5-5C421D862756Q34403458-B65E5CD1-F819-4D85-A943-D1234EFCCB01Q34451386-50E2C658-1067-4324-B1DD-2CA4C448E8BCQ34639366-F73201B2-3527-4DF2-996E-A16E702227E3Q34729910-4C1E6CE4-9C09-4F49-8E2E-4DF28691AC9DQ34784242-95642018-B627-438C-895E-3B51E2E50DC1Q35007082-80C28CA8-35C8-4C6C-8062-E7CB62CABC6FQ35158510-EEBC16F9-BD50-4E31-9292-D8498D80CFF1Q35535182-C608B973-A5AD-454A-8D44-0C6019EBE0B5Q35906885-DE77D308-9A45-41E5-8434-BB09F473DA8CQ36134117-9D3A975F-9837-40DE-99AC-8168C09EFA01Q36226801-DA02331A-4BA3-4324-A569-EB06E21D5A73Q36262938-6DFFC0A1-4FEC-40B3-9F33-125A61D55D75Q36447016-5115B1A4-8708-4156-A774-C9401D253E41
P2860
Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish.
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Automated, quantitative screen ...... ds using transgenic zebrafish.
@ast
Automated, quantitative screen ...... ds using transgenic zebrafish.
@en
Automated, quantitative screen ...... ds using transgenic zebrafish.
@nl
type
label
Automated, quantitative screen ...... ds using transgenic zebrafish.
@ast
Automated, quantitative screen ...... ds using transgenic zebrafish.
@en
Automated, quantitative screen ...... ds using transgenic zebrafish.
@nl
prefLabel
Automated, quantitative screen ...... ds using transgenic zebrafish.
@ast
Automated, quantitative screen ...... ds using transgenic zebrafish.
@en
Automated, quantitative screen ...... ds using transgenic zebrafish.
@nl
P2093
P1433
P1476
Automated, quantitative screen ...... ds using transgenic zebrafish.
@en
P2093
Amy L Rubinstein
Audrey White
Blossom Sneed
Delali Blavo
Eric M Sandberg
Jamil Haider
Raymond Dingledine
T Cameron Tran
Temitope Aiyejorun
Thanh N Doan
P304
11386-11392
P356
10.1158/0008-5472.CAN-07-3126
P407
P577
2007-12-01T00:00:00Z